» Authors » Veerappan R Saravanan

Veerappan R Saravanan

Explore the profile of Veerappan R Saravanan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 69
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Das A, Shah P, Saravanan V, Subramaniam P, Venkatapathy N
Am J Ophthalmol . 2025 Feb; PMID: 40015593
Background: To study and analyze the demographics, clinical features and surgical indications in Congenital X-linked Retinoschisis (CXLRS) in Indian population. Design: Retrospective case series. Methods: It was a retrospective case...
2.
Mahatme C, Shah V, Saravanan V
Vasc Med . 2024 Apr; 29(4):454-456. PMID: 38573120
No abstract available.
3.
Gosalia H, Kumar K, Karan A, Saravanan V, Shah V
Indian J Ophthalmol . 2023 Aug; 71(8):3005-3009. PMID: 37530273
Purpose: To compare glaucomatous from non-glaucomatous optic atrophy using optical coherence tomography (OCT) based on the measurement values of Bruch's membrane opening minimum rim width (BMO-MRW), which is a difficult...
4.
Verghese S, Berkowitz S, Shah V, Shah P, Priya S, Saravanan V, et al.
Indian J Ophthalmol . 2022 Jan; 70(2):448-452. PMID: 35086214
Purpose: To assess the retinal manifestations of Parkinson's disease using optical coherence tomography. Methods: A prospective case-control study comparing 30 eyes from 15 patients with Parkinson's disease and 22 eyes...
5.
Ranjan R, Salian R, Verghese S, Manayath G, Dsouza P, Kanakath A, et al.
Eur J Ophthalmol . 2021 Oct; 32(4):2355-2367. PMID: 34615395
Purpose: To describe the etiology and treatment outcomes of choroidal neovascularization (CNV) in a pediatric population with intravitreal anti-vascular endothelial growth factors (VEGF). Methods: Retrospective single center interventional case series....
6.
Manayath G, Balan R, Ranjan R, Saravanan V, Narendran V
Eur J Ophthalmol . 2021 Jun; 32(3):1610-1618. PMID: 34132140
Purpose: To describe an unusual variant of central serous chorioretinopathy (CSC) presenting as a choroidal elevation with subretinal fluid and its response to accepted treatment modalities of CSC. Design: A...
7.
Dsouza P, Verghese S, Ranjan R, Kumarswamy K, Saravanan V, Manayath G, et al.
Cureus . 2021 Mar; 13(3):e14057. PMID: 33777588
Purpose To evaluate the anatomical and visual outcomes in optic disc pit maculopathy following pars plana vitrectomy (PPV) with inverted internal limiting membrane (ILM) flap Methods Retrospective interventional case series...
8.
Ranjan R, Verghese S, Salian R, Manayath G, Saravanan V, Narendran V
Am J Ophthalmol Case Rep . 2021 Mar; 22:101042. PMID: 33681533
Purpose: To describe the multimodal imaging findings and treatment outcomes in choroidal neovascularization secondary to Choroideremia. Observations: A 13-year-old male presented with reduced visual acuity in the left eye. He...
9.
Bhatta S, Saravanan V, Kumarswamy K, Pant N, Thakur A
Eye (Lond) . 2020 Jan; 34(11):2146-2147. PMID: 31992860
No abstract available.
10.
Manayath G, Ranjan R, Karandikar S, Shah V, Saravanan V, Narendran V
Oman J Ophthalmol . 2018 Dec; 11(3):200-206. PMID: 30505108
Central serous chorioretinopathy (CSC), the fourth most common nonsurgical retinopathy with a usual self-limiting course, is known to present with persistent or recurrent form with distressing visual loss. Evolution of...